Journey II
Device Recon Knees
PDI 00885556679166
General payments
$12,237,894
Research payments
$1,730,289
Through program year 2025, $12,237,894 in general payments and $1,730,289 in research payments were reported against Journey II (Recon Knees).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $2,284,423 | 354 |
| 2025 | Research | $205,000 | 2 |
| 2024 | General | $3,717,073 | 1,027 |
| 2024 | Research | $553,245 | 8 |
| 2023 | General | $2,590,381 | 670 |
| 2023 | Research | $293,326 | 14 |
| 2022 | General | $3,645,708 | 1,251 |
| 2022 | Research | $678,718 | 13 |
| 2021 | General | $309 | 3 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 10 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 29 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
3,305 general · 37 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.